Biosimulation Technology Market Research Report by Form, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19

The Global Biosimulation Technology Market is segmented on the lines of its application and regional. Application segmentation is further classified into drug discovery and drug development. Drug discovery is classified into lead identification, target identification, lead optimization and target validation. Under drug development segmentation it covers in patient validation and preclinical testing and clinical trials. The Global Biosimulation technology market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Global Biosimulation Technology Market is expected to exceed more than US$ 3500 million by 2024 and will grow at a CAGR of more than 15% in the given forecast period.

Browse Full Report:

Biosimulation is PC aided mathematical simulation of biological structures and methods. Biosimulation is used for version based total calculation of biological structures. The primary motive for the development of biosimulation is the growing use of pharmacodynamic and pharmacokinetic (PKPD) model in pre-scientific drug development. Biosimulation refers to simulation of biological procedures by using laptop application. Biosimulation technology has wide utility in drug discovery and development. Its miles a predictive device and used in discovery level to decide the destiny effects of current experimental trials.

The major driving factors of Global Biosimulation Technology Market are as follows:

•    High healthcare expenditure
•    Enhanced simulation technology
•    Advanced software programs

The restraining factors of global Biosimulation Technology market are as follows:

•    Lack of standard method for biosimulation
•    High risk of failure of drugs in biosimulation

This report provides:

1) An overview of the global market for Global Biosimulation Technology Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Biosimulation Technology Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for Global Biosimulation Technology Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Accelrysinc., Schrodinger, ACD/Labs, LeadScope, Certara, Rhenovia, Archimedes, Genedata and Insilico BioTechnology. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Biosimulation Technology Market has been segmented as below: 

By Application Analysis

  •  Drug Discovery
    o    Lead Identification
    o    Target Identification
    o    Lead Optimization
    o    Target Validation
    •    Drug Development
    o    In Patient Validation
    o    Preclinical Testing and Clinical Trials

By Regional Analysis

  •  North America
    •    Europe
    •    Asia-Pacific
    •    Rest of the World

Reasons to Buy this Report: 

1) Obtain the most up to date information available on all Global Biosimulation Technology Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Biosimulation Technology Market data.
4) Assess your competitor’s refining portfolio and its evolution.

Request Sample Report from here:

Table of Contents:


1.1    Key Take Aways
1.2    Report Description
1.3    Markets Covered
1.4    Stakeholders
1.5    Research Methodology
1.5.1    Market Size
1.5.2    Market Share
1.5.3    Key Data Points From Secondary Sources
1.5.4    Key Data Points From Primary Sources

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Application
5.2.3 By End User
5.3 Market Dynamics
5.3.1 Drivers Growth in the Pharmaceutical and Biotechnology Industries Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries Technological Advancements Need to Curtail Drug Discovery and Development Costs Growth in the Biologics and Biosimilars Market and Increased Use of Personalized Medicines
5.3.2 Restraints Lack of Standardization Lack of Trained Professionals
5.3.3 Opportunities Emerging Applications
5.3.4 Challenges Limited Knowledge of Biological Systems and Processes
5.3.5 Trends Collaborations of Universities and Research Labs With Suppliers

6 Biosimulation Market, By Product

7 Biosimulation Market, By Application

8 Biosimulation Market, By End User

9 Global Biosimulation Market, By Region

10 Competitive Landscape
     10.1 Introduction
10.2 Strategic Overview
10.3 Leading Players in the Biosimulation Market
10.4 Competitive Situation and Trends
10.4.1 Product Upgradation
10.4.2 Agreements, Collaborations, Expansions, and Partnerships
10.4.3 New Product and Service Launches
10.4.4 Acquisitions
10.4.5 Other Developments

11 Company Profiles
     11.1 Introduction
11.2 Certara USA, Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments

11.3 Simulation Plus Inc.
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments

11.4 Dassault Systèmes SA
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments

11.5 Schrödinger Inc.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments

11.6 Advanced Chemistry Development, Inc.
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments

11.7 Chemical Computing Group, Inc.
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments

11.8 Entelos Holding Corporation
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments

11.9 Genedata Ag
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments

11.10 Physiomics PLC
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments

11.11 Rhenovia Pharma Ltd.
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments

Other Related Market Research Reports:

Brain Tumour Therapeutics Market Business Scope for Forecast period 2024


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States